{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:17:25Z","timestamp":1778228245852,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023368","name":"Eisai Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020975","name":"UCB Pharma SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001064","name":"Epilepsy Society of Australia Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.eplepsyres.2024.107316","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:46:21Z","timestamp":1706823981000},"page":"107316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy"],"prefix":"10.1016","volume":"200","author":[{"given":"Frank J.E.","family":"Vajda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison A.","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Perucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie M.","family":"Lander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervyn J.","family":"Eadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.eplepsyres.2024.107316_bib1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107316_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yebeh.2018.12.031","article-title":"Fetal antiepileptic drug exposure and learning and memory functioning at 6\u00a0years of age: the NEAD prospective observational study","volume":"92","author":"Cohen","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"10","key":"10.1016\/j.eplepsyres.2024.107316_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2011.133","article-title":"Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations","volume":"68","author":"Holmes","year":"2011","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107316_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3325\/cmj.2018.59.13","article-title":"Effect of antiepileptic drug comedication on lamotrigine concentrations","volume":"59","author":"Lovri\u0107","year":"2018","journal-title":"Croat. Med. J."},{"issue":"1","key":"10.1016\/j.eplepsyres.2024.107316_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/157488611794480061","article-title":"The effect of lamotrigine on valproic acid concentrations","volume":"6","author":"Martin","year":"2011","journal-title":"Curr. Drug Saf."},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107316_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00007691-200210000-00009","article-title":"Does lamotrigine influence valproate concentrations?","volume":"24","author":"Mataringa","year":"2002","journal-title":"Ther. Drug Monit."},{"issue":"16","key":"10.1016\/j.eplepsyres.2024.107316_bib7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.eplepsyres.2024.107316_bib8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/01.wnl.0000238522.79277.9c","article-title":"Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives","volume":"67","author":"Ohman","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.eplepsyres.2024.107316_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.seizure.2007.11.017","article-title":"Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites","volume":"17","author":"Ohman","year":"2007","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.eplepsyres.2024.107316_bib10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/01.wnl.0000238522.79277.9c","article-title":"Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives","volume":"67","author":"Tomson","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.eplepsyres.2024.107316_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.eplepsyres.2024.107316_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jocn.2010.05.008","article-title":"The Australian Pregnancy Register of Anti-epileptic Drugs: 10 years of progress","volume":"17","author":"Vajda","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.eplepsyres.2024.107316_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.eplepsyres.2024.107316_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1528-1167.2009.02336.x","article-title":"The teratogenic risk of antiepileptic drug polytherapy","volume":"51","author":"Vajda","year":"2010","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.eplepsyres.2024.107316_bib15","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","article-title":"Effect of antiepileptic drug comedication on lamotrigine clearance","volume":"62","author":"Weintraub","year":"2005","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2024.107316_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T03:17:06Z","timestamp":1736219826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121124000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":16,"alternative-id":["S0920121124000317"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107316","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107316"}}